Skip to content

Talk Bio

Actionable Insights Powered by AI

Subscribe
  • Privacy policy
  • Subscribe
  • Home
  • Pharma
  • Page 5

Pharma

  • DATE
  • ENTITY
  • Injury or Poisoning

Fierce Biotech Layoff Tracker 2024: Industry-Wide Job Cuts Continue

11 months ago talkbio0Tagged 2024, Biotech Layoffs, Industry, MEI, Pharma

Biotech Layoffs, 2024, MEI Pharma, Rapt Therapeutics, Industry Cuts

Read More
  • ENTITY
  • Occupational Activity
  • ORG

MEI Pharma’s Leadership Shakeup: CEO and Medical Head Step Down Amidst Wind-Down Considerations

11 months ago talkbio0Tagged CEO, Flatulence, MEI, Pharma, strategic alternatives

MEI Pharma, wind down, CEO, medical head, strategic alternatives

Read More
  • ENTITY
  • Geographic Area
  • Health Care Related Organization

Grünenthal Acquires US-Based Valinor Pharma for $250 Million

11 months ago talkbio0Tagged Acquisition, Drug Industry, expansion, Grünenthal, Market, Movantik, naloxegol, Pain management, Pharma, U.S., Valinor

Grünenthal, Valinor Pharma, acquisition, Movantik, naloxegol, opioid-induced constipation, pain management, US market expansion, pharmaceutical industry

Read More
  • Activity
  • Diagnostic Procedure
  • ENTITY

Grünenthal Expands US Presence with $250 Million Acquisition of Valinor Pharma and Movantik

11 months ago talkbio0Tagged Acquisition (action), Drug Industry, expansion, Grünenthal, Movantik, Pharma, Valinor

Grünenthal, Valinor Pharma, Movantik, Acquisition, US Expansion, Pharmaceutical Industry

Read More
  • DATE
  • ENTITY
  • Health Care Related Organization

How the world’s biggest pharma and biotech companies paid their typical worker in 2023

11 months ago talkbio0Tagged 2023, Pharma, Worker

Pharma, Worker, 2023

Read More
  • ENTITY
  • Manufactured Object
  • Occupation or Discipline

How the world’s biggest pharma and biotech companies paid their typical worker in 2023

11 months ago talkbio0Tagged Midline (qualifier value), Pharma, Wages, Worker

Midline (qualifier value), Wages, Pharma, Worker

Read More
  • Biologically Active Substance
  • Disease or Syndrome
  • ENTITY

Ensho Therapeutics Launches with Phase 2-Ready Oral α4β7 Inhibitor for Inflammatory Bowel Disease